Table 2.
Treatment | USA/western Europe (n = 81) | Eastern Europe/South America (n = 118) | Korea and other Asia (n = 94) | Japan (n = 94) |
---|---|---|---|---|
Total | 30 (37) | 17 (14) | 57 (61) | 72 (77) |
Paclitaxel | 3 | 2 | 15 | 52 |
Docetaxel | 12 | 2 | 24 | 13 |
Irinotecan | 10 | 7 | 22 | 32 |
5-Fluorouracil | 14 | 6 | 32 | 18 |
S-1 | 0 | 0 | 9 | 14 |
Capecitabine | 4 | 2 | 2 | 0 |
Methotrexate | 0 | 0 | 2 | 12 |
Folinic acid | 8 | 5 | 26 | 5 |
Cisplatin | 2 | 3 | 10 | 7 |
Oxaliplatin | 2 | 2 | 17 | 3 |
Data are expressed as n (%) or n